Theravance Biopharma, Inc. · NASDAQ:TBPH
BlackRock, Inc. reported a 6.50% stake in Theravance Biopharma, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
BlackRock, Inc. reported a 6.50% stake in Theravance Biopharma, Inc., 3,235,696 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 3,235,696
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.50% | 3,235,696 |
Source
Related
- Theravance Biopharma, Inc.
- BlackRock, Inc.
- Theravance Biopharma, Inc. shareholders
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026